Article info

Download PDFPDF

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

Authors

  1. a akamat{at}mdanderson.org
  2. b joaquim_bellmunt{at}dfci.harvard.edu
  3. c matthew.galsky{at}mssm.edu
  4. d brkonety{at}umn.edu
  5. e dlamm{at}bcgoncology.com
  6. f davidlangham5{at}gmail.com
  7. g cheryl.lee{at}osumc.edu
  8. h matt_milowsky{at}med.unc.edu
  9. i michael-odonnell{at}uiowa.edu
  10. j podonnel{at}medicine.bsd.uchicago.edu
  11. k daniel.petrylak{at}yale.edu
  12. l padsharma{at}mdanderson.org
  13. m skinnere{at}stanford.edu
  14. n gsonpavde{at}uabmc.edu
  15. o jtaylor27{at}kumc.edu
  16. p pvabraham{at}mdanderson.org
  17. q rosenbj1{at}mskcc.org
View Full Text

Citation

Kamat AM, Bellmunt J, Galsky MD, et al
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

Publication history

  • Received April 7, 2017
  • Accepted July 25, 2017
  • First published August 15, 2017.
Online issue publication 
August 15, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.